NeuWave Medical
About
NeuWave Medical, Inc. develops and commercializes energy-based minimally invasive medical devices to physicians and medical centers worldwide. The company develops medical devices that deliver energy to human body to treat various medical conditions. It develops Certus 140, an ablation system that is used for maximizing power delivery to soft tissues, as well as for minimizing invasiveness; and Ablation Confirmation, a computed tomography image processing software package that assists physicians in identifying ablation targets, assessing proper ablation probe placement, and confirming ablation zones post-procedure. NeuWave Medical, Inc. was formerly known as NeuWave Therapy, Inc. and changed its name to NeuWave Medical, Inc. in March 2008. The company was founded in 2004 and is based in Madison, Wisconsin. As of April 14, 2016, NeuWave Medical, Inc. operates as a subsidiary of Ethicon, Inc.